PL2393477T3 - Zastosowanie kompozycji glikokortykoidów do leczenia ciężkiej i niekontrolowanej astmy - Google Patents
Zastosowanie kompozycji glikokortykoidów do leczenia ciężkiej i niekontrolowanej astmyInfo
- Publication number
- PL2393477T3 PL2393477T3 PL10705986T PL10705986T PL2393477T3 PL 2393477 T3 PL2393477 T3 PL 2393477T3 PL 10705986 T PL10705986 T PL 10705986T PL 10705986 T PL10705986 T PL 10705986T PL 2393477 T3 PL2393477 T3 PL 2393477T3
- Authority
- PL
- Poland
- Prior art keywords
- severe
- treatment
- uncontrolled asthma
- glucocorticoid composition
- glucocorticoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/365,754 US20100196483A1 (en) | 2009-02-04 | 2009-02-04 | Method for treatmentof severe and uncontrollable asthma |
| EP10705986.7A EP2393477B1 (en) | 2009-02-04 | 2010-02-03 | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
| PCT/EP2010/051321 WO2010089330A1 (en) | 2009-02-04 | 2010-02-03 | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2393477T3 true PL2393477T3 (pl) | 2018-06-29 |
Family
ID=42153807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10705986T PL2393477T3 (pl) | 2009-02-04 | 2010-02-03 | Zastosowanie kompozycji glikokortykoidów do leczenia ciężkiej i niekontrolowanej astmy |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100196483A1 (pl) |
| EP (2) | EP2393477B1 (pl) |
| JP (1) | JP5886630B2 (pl) |
| KR (1) | KR20110122671A (pl) |
| CN (2) | CN104306360A (pl) |
| AU (1) | AU2010210183B2 (pl) |
| BR (1) | BRPI1008227A8 (pl) |
| CA (1) | CA2751443C (pl) |
| DK (1) | DK2393477T3 (pl) |
| ES (1) | ES2659328T3 (pl) |
| HU (1) | HUE038553T2 (pl) |
| IL (1) | IL213959A (pl) |
| MX (1) | MX2011008200A (pl) |
| NO (1) | NO2393477T3 (pl) |
| NZ (1) | NZ594210A (pl) |
| PL (1) | PL2393477T3 (pl) |
| PT (1) | PT2393477T (pl) |
| RU (1) | RU2519344C2 (pl) |
| SG (1) | SG173538A1 (pl) |
| SI (1) | SI2393477T1 (pl) |
| UA (1) | UA102587C2 (pl) |
| WO (1) | WO2010089330A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
| JP6174056B2 (ja) | 2012-03-09 | 2017-08-02 | ベクチュラ・ゲーエムベーハー | 吸入用装置及び吸入用装置のための混合流路 |
| WO2014012954A1 (en) * | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
| WO2014150245A1 (en) * | 2013-03-15 | 2014-09-25 | Aradigm Corporation | Methods for inhalation of smoke-free nicotine |
| US8807131B1 (en) | 2013-06-18 | 2014-08-19 | Isonea Limited | Compliance monitoring for asthma inhalers |
| AU2014332080B2 (en) | 2013-10-08 | 2020-02-27 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
| WO2015110394A1 (en) * | 2014-01-22 | 2015-07-30 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier) |
| MX2016012712A (es) * | 2014-04-04 | 2017-03-31 | Lam Therapeutics Inc | Una formulacion de rapamicina inhalable para tratar afecciones relacionadas con la edad. |
| SG11201610685XA (en) * | 2014-06-25 | 2017-01-27 | Optinose As | Nasal administration |
| RU2732908C2 (ru) | 2014-10-07 | 2020-09-24 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии |
| RU2611406C1 (ru) * | 2015-09-03 | 2017-02-21 | Общество с ограниченной ответственностью "Биосурф" (ООО "Биосурф") | Способ лечения бронхиальной астмы |
| EP3984579A1 (en) | 2016-07-08 | 2022-04-20 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| MX2019006702A (es) | 2016-12-09 | 2019-08-01 | Trudell Medical Int | Nebulizador inteligente. |
| CA3086890A1 (en) | 2018-01-04 | 2019-07-11 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| WO2021038467A1 (en) | 2019-08-27 | 2021-03-04 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| US11593679B2 (en) * | 2019-11-29 | 2023-02-28 | Kpn Innovations, Llc. | Method of and system for generating a longevity element and an instruction set for a longevity element plan |
| US20220246260A1 (en) * | 2021-01-29 | 2022-08-04 | AsthmaTek, Inc. | Systems and methods to determine a therapy regimen to treat asthma of a subject |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19720701A1 (de) * | 1997-05-16 | 1998-11-19 | Gsf Forschungszentrum Umwelt | Vorrichtung zur Applikation eines Medikament-Aerosols über die Lunge |
| US6187765B1 (en) * | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| DE19851279B4 (de) * | 1998-06-17 | 2006-05-24 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge |
| DE19912265A1 (de) * | 1999-03-18 | 2000-09-21 | Gsf Forschungszentrum Umwelt | Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß |
| DE19912461B4 (de) * | 1999-03-19 | 2006-07-20 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken |
| DE10013093B4 (de) * | 2000-03-17 | 2005-12-22 | Inamed Gmbh | Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole |
| DE10029119B4 (de) * | 2000-06-14 | 2005-12-22 | Institut für Aerosol Medizin InAMed GmbH | Inhalationsvorrichtung |
| DE10123749A1 (de) * | 2001-05-16 | 2002-12-12 | Inamed Gmbh | Vorrichtung zum Verabreichen von Aerosolen |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| AU2004311478A1 (en) * | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| ES2414869T3 (es) * | 2005-03-08 | 2013-07-23 | Activaero Gmbh | Dispositivo de inhalación |
| EP1741460B1 (de) * | 2005-07-06 | 2007-09-19 | Activaero GmbH | Regelbares Ventil und Inhalationsvorrichtung |
| KR100802292B1 (ko) * | 2006-07-21 | 2008-02-11 | 동부일렉트로닉스 주식회사 | 마스크 및 이를 이용한 마이크로 렌즈 제작 방법 |
| CN101795565A (zh) * | 2007-06-28 | 2010-08-04 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| CA2740360A1 (en) * | 2008-10-14 | 2010-04-22 | Activaero Gmbh | Method for treatment of copd and other pulmonary diseases |
-
2009
- 2009-02-04 US US12/365,754 patent/US20100196483A1/en not_active Abandoned
-
2010
- 2010-02-03 NO NO10705986A patent/NO2393477T3/no unknown
- 2010-02-03 HU HUE10705986A patent/HUE038553T2/hu unknown
- 2010-02-03 EP EP10705986.7A patent/EP2393477B1/en not_active Revoked
- 2010-02-03 UA UAA201110621A patent/UA102587C2/ru unknown
- 2010-02-03 CN CN201410371150.3A patent/CN104306360A/zh active Pending
- 2010-02-03 RU RU2011135824/15A patent/RU2519344C2/ru active
- 2010-02-03 CA CA2751443A patent/CA2751443C/en active Active
- 2010-02-03 DK DK10705986.7T patent/DK2393477T3/en active
- 2010-02-03 KR KR1020117017903A patent/KR20110122671A/ko active Search and Examination
- 2010-02-03 PT PT107059867T patent/PT2393477T/pt unknown
- 2010-02-03 ES ES10705986.7T patent/ES2659328T3/es active Active
- 2010-02-03 AU AU2010210183A patent/AU2010210183B2/en active Active
- 2010-02-03 NZ NZ594210A patent/NZ594210A/xx unknown
- 2010-02-03 CN CN201080006616XA patent/CN102307567A/zh active Pending
- 2010-02-03 EP EP17206605.2A patent/EP3338782A1/en active Pending
- 2010-02-03 PL PL10705986T patent/PL2393477T3/pl unknown
- 2010-02-03 WO PCT/EP2010/051321 patent/WO2010089330A1/en active Application Filing
- 2010-02-03 SG SG2011056207A patent/SG173538A1/en unknown
- 2010-02-03 MX MX2011008200A patent/MX2011008200A/es active IP Right Grant
- 2010-02-03 JP JP2011548677A patent/JP5886630B2/ja active Active
- 2010-02-03 SI SI201031650T patent/SI2393477T1/en unknown
- 2010-02-03 BR BRPI1008227A patent/BRPI1008227A8/pt not_active Application Discontinuation
-
2011
- 2011-07-06 IL IL213959A patent/IL213959A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20100196483A1 (en) | 2010-08-05 |
| EP2393477A1 (en) | 2011-12-14 |
| AU2010210183B2 (en) | 2014-09-11 |
| WO2010089330A1 (en) | 2010-08-12 |
| ES2659328T3 (es) | 2018-03-14 |
| KR20110122671A (ko) | 2011-11-10 |
| NO2393477T3 (pl) | 2018-05-26 |
| UA102587C2 (ru) | 2013-07-25 |
| RU2011135824A (ru) | 2013-03-10 |
| MX2011008200A (es) | 2011-10-21 |
| BRPI1008227A2 (pt) | 2016-03-08 |
| CA2751443A1 (en) | 2010-08-12 |
| RU2519344C2 (ru) | 2014-06-10 |
| BRPI1008227A8 (pt) | 2018-12-11 |
| JP2012516873A (ja) | 2012-07-26 |
| HUE038553T2 (hu) | 2018-10-29 |
| IL213959A (en) | 2015-05-31 |
| SG173538A1 (en) | 2011-09-29 |
| NZ594210A (en) | 2013-09-27 |
| PT2393477T (pt) | 2018-02-14 |
| IL213959A0 (en) | 2011-08-31 |
| EP2393477B1 (en) | 2017-12-27 |
| CN104306360A (zh) | 2015-01-28 |
| JP5886630B2 (ja) | 2016-03-16 |
| DK2393477T3 (en) | 2018-04-09 |
| CN102307567A (zh) | 2012-01-04 |
| AU2010210183A1 (en) | 2011-07-28 |
| EP3338782A1 (en) | 2018-06-27 |
| SI2393477T1 (en) | 2018-04-30 |
| CA2751443C (en) | 2018-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL213959A0 (en) | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
| EP2450046A4 (en) | MEDICALLY ACTIVE COMPOSITION FOR THE TREATMENT OF BRONCHITIS AND PREPARATION THEREOF | |
| EP2486061A4 (en) | COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTICS | |
| IL220129A (en) | History of benzamide, preparations containing them and their use in the treatment of cancer | |
| HK1220631A1 (zh) | 用於遞送治療劑的陰離子核心組合物以及製備和使用所述組合物的方法 | |
| SI2477992T1 (sl) | Postopki za pripravo darunavirja in njega amorfne oblike | |
| HK1166305A1 (zh) | 用於治療炎症的組合物及方法 | |
| EP2506967A4 (en) | NANOPARTICLE COMPOSITION AND METHODS OF PREPARATION | |
| IL225227A0 (en) | Preparations including fulvestrant and methods of use | |
| EP2497482A4 (en) | COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES | |
| EP2519100A4 (en) | INTERMEDIATE COMPOUNDS AND METHODS FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | |
| EP2464383A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU | |
| IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
| HK1171677A1 (en) | Composition for the treatment of hemorrhoids and related diseases | |
| EP2437738A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
| PL2493496T3 (pl) | Zastosowanie GSTP1 | |
| EP2514425A4 (en) | COMPOSITION CONTAINING PROTOPANAXATRIOL AND PROTOPANAXADIOL | |
| GB0908174D0 (en) | Steroid containing composition and uses thereof | |
| PL2375912T3 (pl) | Kompozycje i sposoby leczenia uczucia dyskomfortu gardła | |
| EP2377934A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMOR AND ASTHMA | |
| EP2411031A4 (en) | Methods and compositions for the treatment of cancer | |
| EP2406244A4 (en) | ESTROGEN COMPOUNDS AND METHOD FOR THEIR USE | |
| PL388575A1 (pl) | Nowy 7-O-β -D-4'''metoksyglukopiranozyd 8-prenylonaringeniny i sposób jego wytwarzania | |
| EP2467375A4 (en) | FORMS OF DEXLANDSOPRAZOLE AND METHOD OF MANUFACTURING THEREOF | |
| EP2385840A4 (en) | MATERIALS AND METHOD FOR TREATING BLOOD HIGH PRESSURE |